Calcium phosphates as drug delivery systems

Journal of Biomaterials and Tissue Engineering

Volumn 2, Issue 4, 2012, Pages 269-279

  Victor, Sunita Prem ^a   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Bioactive; Calcium phosphate cement; Calcium phosphates; Drug delivery; Nanophase ceramics; Resorbable; Scaffolds

Indexed keywords

EID: 84891635836     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2012.1056     Document Type: Review

References (102)

1. M. Bohner, Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Int. J. Care Injured 31, 37 (2000).
2. L. Di Silvio and W. Bonfield, Biodegradable drug delivery system for the treatment of bone infection and repair. J. Mater. Sci. Mater. Med. 10, 653 (1999).
3. M. A. Rauschmann, T. A. Wichelhaus V. Stirnal, E. Dingeldein, L. Zichner, and R. Schnettler, Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomater. 26, 2677 (2005).
4. L. L. Hench, Bioceramics-From concept to clinic. J. Am. Ceram. Soc. 7, 1482 (1991).
5. L. L. Hench, Biomaterials-A forecast for the future. Biomater. 19, 1419 (1998).
6. W. J. Habraken, J. G. C. Wolke, and J. A. Jansen, Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug. Deliver. Rev. 59, 234 (2007).
7. S. J. Kalita, A. Bhardwaj, and H. A. Bhatt, Nanocrystalline, calcium, phosphate, ceramics in biomedical Engineering. Mater. Sci. Engg. C 27, 441 (2007).
8. S. Deb, L. Aiyathurai, J. A. Roether, and Z. B. Luklinska, Development of high-viscosity, two-paste bioactive bone cements. Biomater. 26, 3713 (2005).
9. E. Fernandez, F. J. Gill, M. P. Ginebra, F. C. Driessens, J. A. Planell, and S. M. Best, Calcium phosphate bone cements for clinical applications. I: Solution chemistry. J. Mater. Sci. Mater. Med. 10, 177 (1999).
10. M. P. Ginebra, E. Fernandez, A. DeMaeyer, R. M. Verbeeck, M. G. Boltong, J. Ginebra, F. C. Driessens, and J. A. Planell, Setting reaction and hardening of an apatitic calcium phosphate cement. J. Dent. Res. 76, 905 (1997).
11. G. Daculsi, Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomater. 19, 1473 (1998).
12. L. E. Carey, H. H. K. Xu, C. G. Simon, S. Takagi, and L. C. Chow, Premixed rapid-setting calcium phosphate composites for bone repair. Biomater. 26, 5002 (2005).
13. M. Bohner, New hydraulic cements based on a-tricalcium phosphate-calcium sulfate dihydrate mixtures. Biomater. 25, 741 (2004).
14. C. Zahraoui and P. Sharrock, Influence of sterilization on injectable bone biomaterials. Biomater. 25, 63 (1999).
15. S. Kannan, I. A. F. Lemos, J. H. G. Rocha, and J. M. F. Ferreira, Synthesis and characterization of magnesium substituted biphasic mixtures of controlled hydroxyapatite/β-tricalcium phosphate ratios. J. Solid State Chem. 178, 3190 (2005).
16. T. S. Sampathkumar, I. Manjubala, and J. Gunasekharan, Synthesis of carbonated calcium phosphate ceramics using microwave irradiation. Biomater. 21, 1623 (2000).
17. E. Mavropoulos, A. M. Rossi, C. C. Nilce, D. Rocha, A. Gloria, G. A. Soares, J. Moreira, and T. G. Moure, Dissolution of calciumdeficient hydroxyapatite synthesized at different conditions. Mater. Charact. 50, 203 (2003).
18. M. M. Monteiro, N. C. C. Rocha, A. M. Rossi, and G. A. Soares, Dissolution properties of calcium phosphate granules with different compositions in simulated body fluid. J. Biomed. Mater. Res. 65, 299 (2003).
19. L. Obadia, G. Amador, G. Daculsi, and J. M. Boulder, Calciumdeficient apatite: Influence of granule size and consolidation mode on release and in vitro activity of vancomycin. Biomater. 24, 1265 (2003).
20. R. Pilliar, M. Filiaggi, J. Wells, M. Grynpas, and R. Kandel, Porous calcium polyphosphate scaffolds for bone substitute applications-in vitro characterization Biomater. 22, 963 (2001).
21. H. Fukui, Y. Taki, and Y. Abe, Implantation of New Calcium Phosphate Glass-Ceramics. J. Dent. Res. 56, 1260 (1977).
22. S. Bose, S. Tarafder, J. Edgington, and A. Bandyopadhyay, Calcium phosphate ceramics in drug delivery. J.O. M 63, 93 (2011).
23. M. Otsuka, Y. Matsuda, J. L. Fox, and W. I. Higuchi, Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. J. Pharm. Sci. 84, 733 (1995).
24. T. Gren, C. Bjerre, O. Camber, and G. Ragnarsson, In vitro drug release from porous cellulose matrices. Int. J. Pharm. 141, 51 (1996).
25. K. Hing, B. Annaz, S. Saeed, P. Revell, and T. Buckland, Microporosity enhances bioactivity of synthetic bone graft substitutes. J. Mater. Sci. Mater. Med. 16, 467 (2005).
26. H. H. K. Xu and C. G. Simon, Macroporous scaffold of premixed calcium phosphate bone cement. J. Orthopaed. Res. 22, 535 (2004).
27. A. Almirall, G. Larrecq, J. A. Delgado, S. Martínez, J. A. Planell, and M. P. Ginebra, Hydroxyapatite scaffolds by foaming and hydrolysis of an α-TCP paste. Biomater. 17, 3671 (2004).
28. M. Goldberg, R. Langer, and X. Jia, Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci. Polymer. 18, 241 (2007).
29. T. J. Webster, Nanophase ceramics as improved bone tissue engineering materials. Am. Ceram. Soc. Bull. 82, 23 (2003).
30. T. J. Webster, C. Ergun, R. H. Doremus, R. W. Siegel, and R. Bizios, Enhanced osteoclast-like cell functions on nanophase ceramics. Biomater. 21, 1803 (2000).
31. W. Sun, C. Chu, J. Wang, and H. Zhao, Comparison of periodontal ligament cells responses to dense and nanophase hydroxyapatite. J. Mater. Sci. Mater. Med. 18, 677 (2007).
32. L. H. Tasker, G. J. Sparey-Taylor, and L. D. Nokes, Applications of nanotechnology in orthopaedics. Clin. Orthop. Relat. Res. 456, 243 (2007).
33. T. J. Webster, R. W. Siegel, and R. Bizios, Osteoblast adhesion on nanophase ceramics. Biomater. 20, 1221 (1999).
34. L. Yang, W. S. Brian, and J. W. Thomas, Nanotechnology controlled drug delivery for treating bone diseases. Am. Ceram. Soc. Bull. 89, 24 (2002).
35. I. Zhitomirsky and L. GalOr, Electrophoretic deposition of hydroxyapatite. J. Mater. Sci. Mater. Med. 8, 213 (1997).
36. W. Paul and C. P. Sharma, Bioceramics, towards nano-enabled drug delivery: A mini review. J. Mater. Sci. Lett. 14, 1792 (1995).
37. W. Paul and C. P. Sharma, Ceramic drug delivery-A perspective. J. Biomater. Appl. 17, 253 (2003).
38. W. Zafirau, D. Parker, W. Billotte, and P. K. Bajpai, Development of a ceramic device for the continuous local delivery of steroids. Biomed. Sci. Instrum. 32, 63 (1996).
39. K. de Groot, Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach, Ceram. Int. 19, 363 (1993).
40. D. J. Netz, P. Sepulveda, V. Pandolfelli, A. C. Spadaro, J. B. Alencastre, M. V. Bentley, and J. M. Marchetti, Potential use of gel casting hydroxyapatite porous ceramic as an implantable drug delivery system. Int. J. Pharm. 213, 117 (2001).
41. H. Denisse, E. Van Beek, R. Martinetti, C. Klein, Z. Van der Zee, and A. Ravaglioli, Actinobacillus actinomycetemcomitans in human periodontal diseases. J. Peridont. Res. 32, 40 (1997).
42. M. Itokazu, T. Sugiyama, T. Ohno, E. Wada, and Y. Katagiri, Development of porous apatite ceramic for local delivery of chemotherapeutic agents. J. Biomed. Mater. Res. 39, 536 (1998).
43. M. Stigter, J. Bezemer, K. de Groot, and P. Layrolle, J. Controll. Rel. 99, 127 (2004).
44. H. Denissen, E. Van Beek, C. L. Owik, S. Papapoulos, and Van der Hooff, Ceramic hydroxyapatite implants for the release of biphosphonate. Bone Min. 35, 123 (1994).
45. A. Ucida, Y. Shinto, N. Araki, and K. Ono, Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J. Orthop. Res. 10, 440 (1992).
46. A. Barroug, L. T. Kuhn, L. C. Gerstenfeld, and M. J. Glimcher, Interactions of cisplatin with calcium phosphate nanoparticles: In vitro controlled adsorption and release. J. Orthop. Res. 22, 703 (2004).
47. Y. Shinto, A. Uchida, F. Korkusuz, N. Araki, and K. Ono, Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J. Bone Joint Surg. Br. 74, 600 (1992).
48. S. P. Victor and C. P. Sharma, Development and evaluation of Cyclodextrin complexed Hydroxyapatite nanoparticles for preferential albumin adsorption. Colloids Surf. B 85, 221 (2011).
49. I. F. Mileti and P. K. Bajpai, Development of a hydroxyapatite ceramic matrix for the continuous delivery of Coumadin. Biomed. Sci. Instrum. 31, 177 (1995).
50. A. Lasserre, S. Berty, and P. K. Bajpai, In vitro and in vivo dapsone release from hydroxyapatite reservoirs. Biomed. Sci. Instrum. 33, 49 (1997).
51. T. B. Palazzoa, M. C. Sidotia, N. Roveria, A. Tampierib, M. Sandrib, L. Bertolazzic, F. Galbuserac, G. Dubinic, P. Venac, and R. Controc, Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach. Mater. Sci. Engg. C 25, 207 (2005).
52. S. D. H. Sarczyk, J. Szymura-Oleksiak, and B. Mycek, The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants. Biomater. 21, 1215 (2000).
53. W. Paul, N. Jerry, and C. P. Sharma, Delivery of insulin from hydroxyapatite ceramic microspheres: Preliminary in vivo studies. J. Biomed. Mater. Res. 61, 660 (2002).
54. S. Padilla, R. P. del Real, and M. Vallet-Regi, In vitro release of gentamicin from OHAp/PEMA/PMMA samples. J. Control. Rel. 83, 343 (2002).
55. Y. Yamashita, A. Uchida, T. Yamakawa, Y. Shinto, N. Araki, and K. Kato, Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int. Orthop. 22, 247 (1998).
56. W. Paul and C. P. Sharma, New composites of hydroxyapatite and bioresorbable macromolecular material. J. Mater. Sci. Mater. Med. 10, 283 (1999).
57. G. Hotz and G. Herr, Bone substitute with osteoinductive biomaterials-Current and future clinical applications. Int. J. Maxillofac. Surg. 23, 413 (1994).
58. C. V. Sarath, B. Ganga, R. V. Suganthi, K. Elayaraja, J. M. I. Ahymah, B. W. Sofi, R. Mythili, V. Ganesh, and K. S. Narayana, Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release. ACS Appl. Mater. Inter. 4, 1200 (2012).
59. Z. Ouardia, T. Sophie, R. Gwenaël, O. M. Med, F. Marina, and S. Patrick, Macroporous calcium phosphate ceramic implants for sustained drug delivery. Mater. Sci. Engg. C 31, 1352 (2011).
60. L. Obadiaa, G. Amadora, G. Daculsia, and J. M. Bouler, Calciumdeficient apatite synthesized by ammonia hydrolysis of dicalcium phosphate dihydrate: Influence of temperature, time, and pressure. Biomater. 24, 2003 (1265).
61. S. P. Victor and T. S. Sampath Kumar, Tailoring calcium-deficient hydroxyapatite nanocarriers for enhanced release of antibiotics. J. Biomed. Nanotech. 4, 203 (2008).
62. J. Solen, F. Corinne, G. Soueidanb, G. Grimandi, M. Dominique, A. Bruno, J. Pascal, L. Samia, P. Paul, G. Olivier, D. Guy, G. Jerome, B. Bruno, and M. B. Jean, Novel biomaterials for bisphosphonate delivery. Biomater. 26, 2073 (2005).
63. H. A. Benghuzzi, B. G. England, and P. K. Bajpai, Tricalcium phosphate amino acid capsules as a drug delivery system for steroid hormones. Biomed. Sci. Instrum. 27, 197 (1991).
64. H. A. Benghuzzi, P. K. Bajpi, and B. G. England, Suppression of spermatogenesis by means of continuous delivery of danazol in combination with dihydrotestosterone from ALCAP drug delivery devices. J. Biomed. Sci. Instrum. 26, 141 (1990).
65. H. A. Benghuzzi, R. M. Barbaro, and P. K. Bajpai, In vitro release of azidothymidine (AZT) by ceramic drug delivery systems. J. Biomed. Sci. Instrum. 26, 151 (1990).
66. J. A. Pope, H. Benghuzzi, B. England, and Z. Cason, Morphometric analysis of the adrenal compartments exposed to sustained delivery of androgens. J. Biomed. Sci. Instrum. 37, 155 (2001).
67. J. C. Lambotte, H. Thomazeau, G. Cathelineau, G. Lancien, J. Minet, and F. Langlais, Tricalcium phosphate, an antibiotic carrier: A study focused on experimental osteomyelitis in rabbits. Chirugie 123, 572 (1998).
68. L. Morris and P. K. Bapai, Development of a resorbable tricalcium phosphate (TCP) amine antibiotic composite. Mater. Res. Soc. 110, 293 (1989).
69. Y. Masahiro, T. Hidetomi, I. Yuuki, O. Takao, N. Kazutoshi, I. Hikaru, M. Shimpei, and T. Kunio, Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant. Biomater. 26, 5145 (2005).
70. B. Raia, S. H. Teohb, D. W. Hutmachera, T. Caoa, and K. H. Hoa, Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomater. 26, 3739 (2005).
71. J. M. Bouler, R. Z. LeGeros, and G. Daculsi, Biphasic calcium phosphates: Influence of three synthesis parameters on the HA/beta-TCP ratio. J. Biomed. Mater. Res. 51, 680 (2000).
72. Z. Min, W. Huixue, L. Jiyong, H. Hailong, H. Xuguo, H. Qianjun, Z. Lingxia, Y. Xiaojian, and S. Jianlin, A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomater. 32, 1986 (2011).
73. G. Daculsi, P. Weiss, J. M. Bouler, O. Gauthier, F. Millot, and E. Aguado, Biphasic calcium phosphate/hydrosoluble polymer composites: A new concept for bone and dental substitution biomaterials. Biomater. 25, 59 (1999).
74. P. Weiss, O. Gauthier, M. Bouler, G. Grimandi, and G. Daculsi, Injectable bone substitute using a hydrophilic polymer. Bone 25, 67 (1999).
75. M. K. Canon and P. K. Bajpai, Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics. J. Biomed. Sci. Instrum. 31, 159 (1995).
76. H. Denissen, R. Martinetti, A. Van Lingen, and A. Van den Hooff, Normal osteoconduction and repair in and around submerged highly bisphosphonate-complexed hydroxyapatite implants in rat tibiae. J. Periodont. 71, 272 (2000).
77. J. Guicheux, O. Gauthier, E. Aguado, P. Pilet, S. Couillaud, D. Jegou, G. Daculsi, and D. Heymann, Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: A rabbit study. J. Bone Miner. Res. 13, 739 (1998).
78. P. Iooss, A. M. Le Ray, G. Grimandi, G. Daculsi, and C. Merle, A new injectable bone substitute combining poly(ε-caprolactone) microparticles with biphasic calcium phosphate granules. Biomater. 22, 2785 (2001).
79. G. Eric, A. Eric, M. N. Jean, P. Norbert, L. G. Laurent, L. Pierre, and D. Guy, Osteointegration of femoral stem prostheses with a bilayered calcium phosphate coating. Biomater. 27, 1119 (2006).
80. S. P. Victor and T. S. Sampath Kumar, BCP ceramic microspheres as drug delivery carriers: Synthesis, characterisation and doxycycline release. J. Mater. Sci. Mater. Med. 19, 283 (2008).
81. M. P. Ginebra, T. Traykova, and J. A. Planell, Calcium phosphate cements as bone drug delivery systems: A review. J. Control. Rel. 113, 102 (2006).
82. S. P. Victor and T. S. Sampath Kumar, Processing and properties of injectable porous apatitic cements. J. Cer. Soc. Japan 1349, 105 (2008).
83. M. Otsuka, Y. Matsuda, Z. Wang, J. L. Fox, and W. I. Higuchi, Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. Pharm. Res. 14, 444 (1997).
84. C. Hamanishi, K. Kitamoto, S. Tanaka, M. Otsuka, Y. Doi, and T. Kitahashi, A self-setting TTCP-DCPD apatite cement for release of vancomycin. J. Biomed. Mater. Res. Appl. Biomater. 33, 139 (1996).
85. M. Bohner, New hydraulic cements based on α-tri calcium phosphate-calcium sulfate dihydrate mixtures. Biomater. 25, 741 (2004).
86. M. Takechi, Y. Miyamoto, Y. Momota, T. Yuasa, S. Tatehara, M. Nagayama, K. Ishikawa, and K. Suzuki, The in vitro antibiotic release from anti-washout apatite cement using chitosan. J. Mater. Sci. Mater. Med. 13, 973 (2002).
87. M. Takechi, Y. Miyamoto, K. Ishikawa, M. Nagayama, M. Kon, K. Asaoka, and K. Suzuki, Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement. J. Biomed. Mater. Res. 39, 308 (1998).
88. M. Bohner, U. Gbureck, and J. E. Barralet, Technological issues for the development of more efficient calcium phosphate bone cements: A critical assessment. Biomater. 26, 6423 (2005).
89. M. P. Ginebra, T. Traykova, and J. A. Planell, Calcium phosphate cements as bone drug delivery systems: A review. J. Control. Rel. 113, 102 (2006).
90. H. P. Stallmann, C. Faber, A. L. J. Bronckers, A. V. N. Amerongen, and P. I. J. M. Wuisman, Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11-or gentamicin-containing calcium phosphate cement. J. Antimicrob, Chemother. 54, 472 (2004).
91. C. H. Alkhraisat, J. Rueda, J. Cabrejos-Asama, J. Lucas-Aparicio, T. Mariño, J. T. García-Denche, L. B. Jerez, U. Gbureck, and E. L. Cabarcos, Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement. Acta Biomat. 6, 1522 (2010).
92. J. Zeltinger, J. K. Sherwood, D. A. Graham, R. Mueller, and L. G. Griffith, Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 7, 557 (2001).
93. O. Gauthier, I. Khairoun, J. Bosco, L. Obadia, X. Bourges, C. Rau, D. Magne, J. M. Bouler, E. Aguado, G. Daculsi, and P. Weiss, Noninvasive bone replacement with a new injectable calcium phosphate biomaterial. J. Biomed Mater. Res. 66, 47 (2003).
94. K. Hae-W, C. K. Jonathan, and K. Hyoun-E, Hydroxyapatite/ poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomater. 25, 1279 (2004).
95. L. Emmanuelle, W. Pierre, G. Bernard, M. Anne, P. Paul, G. Jerome, C. Pierre, B. Jean-M, D. Guy, and M. Olivier, Injectable calcium phosphate scaffold and bone marrow graft for bone reconstruction in irradiated areas: An experimental study in rats. Biomater. 27, 4566 (2006).
96. M. C. Kruyt, C. E. Wilson, J. D. de Bruijn, C. A. van Blitterswijk, C. F. Oner, A. J. Verbout, and W. J. A. Dhert, The effect of cellbased bone tissue engineering in a goat transverse process model. Biomater. 27, 5099 (2006).
97. B. Susmita, T. Solaiman, E. Joe, and B. Amit, Calcium phosphate ceramics in drug delivery. J. Mater. Sci. 63, 93 (2003).
98. W. J. E. M. Habraken, J. G. C. Wolke, and J. A. Jansen, Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Del. Rev. 59, 234 (2007).
99. B. Susmita and T. Solaiman, Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering-A review. Acta Biomater. 8, 1401 (2012).
100. E. V. Giger, J. Puigmartí-Luis, R. Schlatter, B. Castagner, P. S. Dittrich, and J. Leroux, Gene delivery with bisphosphonatestabilized calcium phosphate nanoparticles. J. Control. Rel. 150, 28 (2011).
101. J. H. Adair, M. P. Parette, E. I. Altinǒglu, and M. Kester, Nanoparticulate alternatives for drug delivery. ACS Nano 4, 4967 (2010).
102. D. Chiu, W. Zhou, S. Kitayaporn, D. T. Schwartz, K. Murali-Krishna, T. J. Kavanagh, and F. Baneyx, Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: Potential for vaccine applications. Bioconjugate Chem. 23, 610 (2012).